CD24 and ovarian cancer: A range of malignancies, including ovarian cancer, small cell lung cancer, urothelial cancer, liver cancer, cholangiocarcinoma, colorectal cancer, and esophageal squamous cell carcinoma, have been shown to overexpress CD24 in tumor tissues [18,29].